↓ Skip to main content

Pharmaceutical policy Part 1 The challenge to pharmacists to engage in policy development

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, February 2015
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (77th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter
8 X users

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
56 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pharmaceutical policy Part 1 The challenge to pharmacists to engage in policy development
Published in
Journal of Pharmaceutical Policy and Practice, February 2015
DOI 10.1186/s40545-015-0027-5
Pubmed ID
Authors

Norman C Morrow

Abstract

Across the world medicines are the ubiquitous technology in the diagnosis, treatment and prevention of disease. Pharmaceutical policy, as part of national health care policy, is concerned with the provision and use of medicines. Pharmacists are critical to the medicines management process, yet are often largely detached from policy development. Logically, they should inform Government policies which impact on their work or where their skills could be best applied to implement health care policy and medicines utilisation in particular. It therefore makes it critically important that the pharmaceutical profession engages with national policy makers and in the strategic planning for health care. This is the first of two articles directed to this specific issue. Firstly, it identifies a number of the practice challenges for pharmacy and medicines management, their implications for policy and the need for a balanced approach. Drawing from a range of international experiences some key learning points in respect of formulating and implementing national medicines policies are presented. Finally, reference is made to several authoritative evidence bases to inform the development of pharmaceutical practice and medicines management policies.

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 2%
South Africa 1 2%
Unknown 54 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 13 23%
Student > Ph. D. Student 5 9%
Student > Doctoral Student 4 7%
Student > Bachelor 4 7%
Researcher 4 7%
Other 8 14%
Unknown 18 32%
Readers by discipline Count As %
Medicine and Dentistry 12 21%
Pharmacology, Toxicology and Pharmaceutical Science 9 16%
Social Sciences 5 9%
Nursing and Health Professions 3 5%
Business, Management and Accounting 2 4%
Other 5 9%
Unknown 20 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 March 2019.
All research outputs
#6,360,910
of 25,173,778 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#161
of 491 outputs
Outputs of similar age
#81,658
of 369,789 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#5
of 11 outputs
Altmetric has tracked 25,173,778 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 491 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.1. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 369,789 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.